Conclusions: Gender-related differences exist in the pharmacokinetics of buprenorphine; differences in body composition appear to have a major impact; differences in CYPA-dependent metabolism may also contribute. (Source: Drug and Alcohol Dependence)
Gender differences in pharmacokinetics of maintenance dosed buprenorphine
Previous post: Buprenorphine/naloxone inhibition of remifentanil procedural sedation
Next post: Transfer from high dose methadone to buprenorphine/naloxone.